Charts for: – sales, costs, margins, earnings – current assets, long-term assets, liabilities, debt, equity – cash flows from operations,…
Pfizer (PFE): Not so rosy, with sales in need for a (blue?) pill. Earnings and cash flows so far ok.
Pfizer Financials Q2 2013: Sales down, but gross margin up on lower costs.
Apparently the disposal of Animal Health Business (Zoetis) helped margins significantly.
RSS - Posts